Holding(s) in Company | 20-Aug-2025 | 13:36 | RNS |
Interim Results | 06-Aug-2025 | 07:00 | RNS |
Result of AGM | 12-Jun-2025 | 12:51 | RNS |
Holding(s) in Company | 27-May-2025 | 15:13 | RNS |
Notice of AGM | 20-May-2025 | 07:00 | RNS |
Final Results | 19-May-2025 | 07:00 | RNS |
Warrant Extension, Debt Conversion & Equity Issue | 01-Apr-2025 | 07:00 | RNS |
Extension of Warrants in Incanthera to 30 Sep 2025 | 01-Apr-2025 | 07:00 | RNS |
ImmuPharma proves unique Mechanism of Action-P140 | 13-Mar-2025 | 07:00 | RNS |
Holding(s) in Company | 21-Feb-2025 | 11:36 | RNS |
£2.91m fundraising; related party transacti... | 13-Feb-2025 | 07:00 | RNS |
Response to Share Price Movement | 28-Jan-2025 | 12:57 | RNS |
Breakthrough Findings into Autoimmune Diseases | 09-Jan-2025 | 07:00 | RNS |
Change of Auditor | 23-Dec-2024 | 07:00 | RNS |
Holding(s) in Company | 10-Dec-2024 | 14:36 | RNS |
Currency | UK Pounds |
Share Price | 2.23p |
Change Today | 0.43p |
% Change | 23.78 % |
52 Week High | 5.90 |
52 Week Low | 1.09 |
Volume | 8,524,292 |
Shares Issued | 499.72m |
Market Cap | £11.12m |
RiskGrade | 328 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 41,000 @ 2.34p |
16:26 | 65,000 @ 2.24p |
16:26 | 100,000 @ 2.24p |
16:22 | 9,456 @ 2.22p |
16:20 | 13,823 @ 2.24p |
You are here: research